Policy | March 14, 2022
Draft policy on medical devices released
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
The accelerated growth of Medix Biochemica will establish its status as the ultimate IVD raw materials supplier
Company has bought 7.73 million shares for KRW 146.1 billion thus securing the largest shareholder status in Bukwang Pharmaceutical
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
The acquisition of myPOLS Biotec complements Medix Biochemica’s leading portfolio of IVD raw materials and expands its reagent offerings for molecular diagnostics
Unlike most data analysis services, Dolomite Bio will accept sample sizes ranging from as little as one sample, to as many as the research project requires
This test analyses samples in VTM directly without the need for RNA extraction step
EMBER500RNA Prestain Loading Dye allows single-step denaturing, loading, and bright RNA staining on regular agarose gels
PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products
Subscribe To Our Newsletter & Stay Updated
